Welcome to LookChem.com Sign In|Join Free
  • or
Thorium tetrahydroxide, also known as thorium hydroxide, is a chemical compound with the formula Th(OH)4. It is prepared by adding alkali to a solution of thorium salt, resulting in a gelatinous precipitate that is then dehydrated. Thorium tetrahydroxide has the ability to absorb carbon dioxide (CO2) to form thorium carbonate (ThOCO3).

13825-36-0

Post Buying Request

13825-36-0 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

13825-36-0 Usage

Uses

Used in Nuclear Industry:
Thorium tetrahydroxide is used as a precursor for the production of thorium-based nuclear fuels. Its ability to absorb CO2 and form thorium carbonate makes it a suitable candidate for the development of advanced nuclear fuel cycles, which can potentially offer improved safety, efficiency, and reduced waste compared to traditional uranium-based fuels.
Used in Chemical Research:
Thorium tetrahydroxide is utilized as a research material in the field of inorganic chemistry, particularly for studying the properties and reactions of thorium and its compounds. Its unique chemical properties, such as its ability to form a gelatinous precipitate and absorb CO2, make it an interesting subject for scientific investigation.
Used in Environmental Applications:
Due to its CO2 absorption capabilities, thorium tetrahydroxide can be employed in environmental applications, such as carbon capture and storage technologies. By converting CO2 into a more stable and less harmful form, thorium tetrahydroxide can contribute to the development of solutions for mitigating the effects of climate change and reducing greenhouse gas emissions.

Check Digit Verification of cas no

The CAS Registry Mumber 13825-36-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,3,8,2 and 5 respectively; the second part has 2 digits, 3 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 13825-36:
(7*1)+(6*3)+(5*8)+(4*2)+(3*5)+(2*3)+(1*6)=100
100 % 10 = 0
So 13825-36-0 is a valid CAS Registry Number.
InChI:InChI=1/4H2O.Th/h4*1H2;/p-4

13825-36-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name thorium hydroxide

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:13825-36-0 SDS

13825-36-0Downstream Products

13825-36-0Relevant academic research and scientific papers

Comparisons of plutonium, thorium, and cerium tellurite sulfates

Lin, Jian,Cross, Justin N.,Diwu, Juan,Meredith, Nathan A.,Albrecht-Schmitt, Thomas E.

, p. 4277 - 4281 (2013)

The hydrothermal reaction of PuCl3 or CeCl3 with TeO2 in the presence of sulfuric acid under the comparable conditions results in the crystallization of Pu(TeO3)(SO4) or Ce2(Te2O5)(SO4)2, respectively. Pu(TeO3)(SO4) and its isotypic compound Th(TeO3)(SO4) are characterized by a neutral layer structure with no interlamellar charge-balancing ions. However, Ce 2(Te2O5)(SO4)2 possesses a completely different dense three-dimensional framework. Bond valence calculation and UV-vis-NIR spectra indicate that the Ce compound is trivalent whereas the Pu and Th compounds are tetravalent leading to the formation of significantly different compounds. Pu(TeO3)(SO4), Th(TeO3)(SO4), and Ce2(Te2O 5)(SO4)2 represent the first plutonium/thorium/cerium tellurite sulfate compounds. Our study strongly suggests that the chemistries of Pu and Ce are not the same, and this is another example of the failure of Ce as a surrogate.

Probing the Influence of Acidity and Temperature to Th(IV) on Hydrolysis, Nucleation, and Structural Topology

Lin, Jian,Qie, Meiying,Zhang, Linjuan,Wang, Xiaomei,Lin, Yuejian,Liu, Wei,Bao, Hongliang,Wang, Jianqiang

, p. 14198 - 14205 (2017)

Systematic control of the molar ratio between thorium hydroxides and selenic acid and their reaction temperature under hydrothermal conditions results in four novel thorium-based selenate complexes, namely, [Th8O4(OH)8(SeO4)6(H2O)16]·(SeO4)2·13H2O (Th-1), [Th8O4(OH)8(SeO4)8(H2O)13]·7H2O (Th-2), Th(OH)2(SeO4)H2O (Th-3), and Th3(SeO4)6(H2O)6·2.5H2O (Th-4), as well as the thorium mixed selenite selenate compound Th(SeO3)(SeO4) (Th-5). Smaller [H2SeO4]/[Th(IV)] ratio or lower temperature give rise to the formation of octameric [Th8(μ3-O)4(μ2-OH)8]16+ cores in Th-1/Th-2 and infinite [Th(μ2-OH)2H2O]2+ chains in Th-3, respectively. Increasing the [H2SeO4]/[Th(IV)] ratio or elevating the temperature generates a microporous (11.3 ? voids) open-framework Th-4, a monomeric thorium species without oxo/hydroxyl ligands, and a three-dimensional thorium structure Th-5. Formation of these compounds suggests that variables including acidity and temperature play a critical role in the hydrolysis and oligomerization of ThIV ions. Increasing acidity limits the deprotonation of water molecules and formation of nucleophilic hydroxo/oxo-aquo Th species, and high temperature appears to suppress the olation/oxolation hydrolysis reactions, which in both ways limit the formation of the thorium oligomers.

Structures of dimeric hydrolysis products of thorium

Wilson, Richard E.,Skanthakumar,Sigmon, Ginger,Burns, Peter C.,Soderholm

, p. 2368 - 2372 (2007)

Three unique thorium dimeric compounds have been crystallized from either direct hydrolysis of Th4+(aq)/HCl or titration of Th(OH) 4(am) with Th(NO3)4(aq) and their structures determined using single-crystal X-ray diffraction. The compound [Th 2(μ2-OH)2(NO3)6(H 2O)6]H2O (1) is identical to that identified previously by Johansson. Two additional unreported compounds have been identified, [Th2(μ2-OH)2(NO 3)4(H2O)8](NO3) 2 (2) and [Th2(μ2-OH)2Cl 2(H2O)12]Cl4· 2H2O (3). 1 crystallizes in the monoclinic space group P21/c, with a = 6.792(2) A, b = 11.710(4) A, c = 13.778(5) A, and β = 102.714(5)° and 2 crystallizes in the monoclinic space group P2 1/n, with a = 6.926(5) A, b = 7.207(1), A, c = 21.502(1) A, and β = 96.380(1)°. The chloride-containing dimer, 3, crystallizes in triclinic P1, with a = 8.080(2) A, b = 8.880(2) A, c = 9.013(2) A, α = 97.41(3)°, β = 91.00(3), and γ = 116.54(3)°. We also present high-energy X-ray scattering data demonstrating the presence of the hydroxo-bridged moiety in solution and discuss our findings in the context of known solid-state structures. The three structures demonstrate 11-, 10-, and 9-coordinate thorium, respectively, and coupled with the scattering experiments provide additional structural and chemical insight into tetravalent actinide hydrolysis.

Complexes of Th(iv) with neutral O-N-N-O hybrid ligands: A thermodynamic and crystallographic study

Yang, Yanqiu,Lv, Lina,Liu, Yunnu,Chen, Baihua,Liu, Jun,Li, Xingliang,Luo, Shunzhong

, p. 705 - 714 (2021)

The thermodynamics of Th(iv) complexes with N,N,N′,N′-tetramethyl-2,2′-bipyridine-6,6′-dicarboxamide (TMBiPDA) and N,N,N′,N′-tetramethyl-1,10-phenanthroline-2,9-dicarboxamide (TMPhenDA) in CH3OH/10%(v)H2O (CH3OH?:?H2O = 9?:?1 by volume) were determined by spectrophotometry and calorimetry. The ligand TMBiPDA/TMPhenDA coordinates with the central Th atom by the tetradentate (O-N-N-O) mode, which is validated by 1H NMR in solution and crystallography in the solid. The single crystal X-ray diffraction data show that ten-coordinated thorium coordinates with two ligand molecules and two solvent molecules (water or methanol). Both ThL and ThL2 complexes (L = TMPhenDA or TMBiPDA) were detected in solution. In thermodynamics, the formation of all complexes is driven by both enthalpy and entropy. In a comparison, enthalpy is more favorable to the formation of TMBiPDA complexes, while entropy is more favorable to the formation of TMPhenDA complexes; the entropy advantages of the TMPhenDA complexes override the enthalpy advantages of the corresponding TMBiPDA complexes, giving the TMPhenDA complexes higher stability constants than the TMBiPDA complexes. In crystallography, ligand distortions occur in ThL2 complexes, and TMBiDA distorts more than TMPhenDA does; the Th-O and Th-N bonds involving TMBiPDA are slightly shorter than those involving TMPhenDA.

Characterization of Thorium-Pyrazinoic acid complexation and its decorporation efficacy in human cells and blood

Dumpala, Rama Mohana Rao,Das, Sourav Kumar,Ali, Manjoor,Boda, Anil,Kumar, Pranaw,Rawat, Neetika,Kumar, Amit,Ali, Sk Musharaf

, (2021)

Thorium (Th) exposure to the human beings is a radiochemical hazard and the chelation therapy by suitable drugs is the major prevention approach to deal with. The present studies aimed at usage of pyrazinoic acid (PCA), which is a prodrug to treat tuberculosis, for its usage as decorporating agent for thorium from human body. The present studies provide a comprehensive knowledge on the chemical interaction and biological efficacy of pyrazinoic acid (PCA) for decorporation of Thorium from the human body. The thermodynamic parameters for Th-PCA speciation are determined by both experiment and theory. The potentiometric data analysis and Electro-Spray Ionization Mass Spectrometry (ESI-MS) studies revealed the formation of MLi (i = 1–4) species with the decrease in stepwise stability constants. All the species formations are endothermic reactions and are predominantly entropy-driven. Biological experiments using human erythrocytes, whole blood and normal human lung cells showed cytocompatibility and decorporation ability of PCA for Thorium. Density functional calculations have been carried out to get insights on interaction process at molecular level. The experimental results and theoretical predictions found to be in line with each other. Present findings on complexation of Th by PCA and its evaluation in human cells and blood would further motivate determination of its safety levels and decorporation efficacy in animal models.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 13825-36-0